Funding for this research was provided by:
Received: 15 March 2022
Accepted: 16 October 2022
First Online: 22 October 2022
: The study was approved by the Lund regional ethical review board (Dnr 2017/158). The patients have consented to participate in the Swespine registry.
: Not applicable (Registry Study).
: The authors have no relevant financial or nonfinancial interests to disclose.